Brunswick Corp 8-K Filing

FAQ

Key Financial Figures

• $0.75 — ich Registered Common stock, par value $0.75 per share BC New York Stock Exchang
• $300 million — ate principal amount of its outstanding $300 million 5.100% Senior Notes due 2052 (the "Note
• $50 million — up to an aggregate principal amount of $50 million to up to a maximum aggregate principal
• $100 million — a maximum aggregate principal amount of $100 million (such increased aggregate principal amo
• $111 million — 25, 2025 (the "Early Tender Deadline"), $111 million aggregate principal amount of the Notes

Filing Documents

• form8-k.htm (8-K) — 37KB
• ex99-1.htm (EX-99.1) — 27KB
• ex99-2.htm (EX-99.2) — 24KB
• image0.jpg (GRAPHIC) — 419KB
• 0000950157-25-000973.txt ( ) — 1388KB
• bc-20251126.xsd (EX-101.SCH) — 4KB
• bc-20251126_def.xml (EX-101.DEF) — 17KB
• bc-20251126_lab.xml (EX-101.LAB) — 26KB
• bc-20251126_pre.xml (EX-101.PRE) — 19KB
• form8-k_htm.xml (XML) — 6KB

01. Other Events

Item 8.01. Other Events. On November 26, 2025, Brunswick Corporation (the "Company") issued a press release announcing the early tender results for the previously announced tender offer (the "Offer") to purchase for cash an aggregate principal amount of its outstanding $300 million 5.100% Senior Notes due 2052 (the "Notes"). The Company also announced that it has increased the maximum aggregate principal amount subject to purchase pursuant to the Offer from up to an aggregate principal amount of $50 million to up to a maximum aggregate principal amount of $100 million (such increased aggregate principal amount, the "Tender Cap"). The Offer is being made exclusively pursuant to an offer to purchase, dated November 12, 2025 (the "Offer to Purchase"), as previously amended, which sets forth the terms and conditions of the Offer. As of 5:00 p.m., Eastern Time, on November 25, 2025 (the "Early Tender Deadline"), $111 million aggregate principal amount of the Notes had been validly tendered and not validly withdrawn in the Offer. Because the aggregate principal amount of all of the Notes validly tendered and not validly withdrawn at or prior to the Early Tender Deadline exceeds the Tender Cap, the Company will not accept for purchase all of the Notes that have been validly tendered and not validly withdrawn and will only accept for purchase Notes with an aggregate principal amount equal to the Tender Cap. Accordingly, Notes validly tendered and not validly withdrawn at or prior to the Early Tender Deadline will be subject to proration as described in the Offer to Purchase. The Company will use a proration rate of approximately 90.2% for such Notes and will accept $100 million aggregate principal amount of such Notes for purchase, adjusted for minimum eligible denominations, as permitted by applicable law. The Company expects the settlement of all Notes accepted for purchase to occur on December 1, 2025, subject to all conditions to the Offer having been satisfied or wai

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description of Exhibit 99.1 Press release of the Company, issued November 26, 2025. 99.2 Press release of the Company, issued November 26, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BRUNSWICK CORPORATION Dated: November 26, 2025 By: /s/ Ryan M. Gwillim Name: Ryan M. Gwillim Title: Executive Vice President and Chief Financial and Strategy Officer

View Full Filing

View this 8-K filing on SEC EDGAR